» Articles » PMID: 10712437

High-level Expression of Egr-1 and Egr-1-inducible Genes in Mouse and Human Atherosclerosis

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2000 Mar 11
PMID 10712437
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

To understand the mRNA transcript profile in the human atherosclerotic lesion, RNA was prepared from the fibrous cap versus adjacent media of 13 patients undergoing carotid endarterectomy. cDNA expression arrays bearing 588 known genes indicated that lesions express unexpectedly high levels of the early growth response gene, Egr-1 (NGFI-A), a zinc-finger transcription factor that modulates a cluster of stress-responsive genes including PDGF and TGF-beta. Expression of Egr-1 was an average of 5-fold higher in the lesion than in the adjacent media, a result confirmed by RT-PCR, and many Egr-1-inducible genes were also strongly elevated in the lesion. Time-course analyses revealed that Egr-1 was not induced ex vivo. Immunocytochemistry indicated that Egr-1 was expressed prominently in the smooth muscle-actin positive cells, particularly in areas of macrophage infiltration, and in other cell types, including endothelial cells. Induction of atherosclerosis in LDL receptor-null mice by feeding them a high-fat diet resulted in a progressive increase in Egr-1 expression in the aorta. Thus, induction of Egr-1 by atherogenic factors may be a key step in coordinating the cellular events that result in vascular lesions.

Citing Articles

Early growth response-1, a dynamic conduit in cardiovascular disease.

Khachigian L Front Cardiovasc Med. 2024; 11:1487668.

PMID: 39619154 PMC: 11605393. DOI: 10.3389/fcvm.2024.1487668.


Single-Cell Analyses Offer Insights into the Different Remodeling Programs of Arteries and Veins.

Rojas M, Pereira-Simon S, Zigmond Z, Varona Santos J, Perla M, Santos Falcon N Cells. 2024; 13(10).

PMID: 38786017 PMC: 11119253. DOI: 10.3390/cells13100793.


Transfection of Vein Grafts with Early Growth Response Factor-1 Oligodeoxynucleotide Decoy: Effects on Stem-Cell Genes and Toll-like Receptor-Mediated Inflammation.

Mylonas K, Peroulis M, Kapelouzou A Int J Mol Sci. 2023; 24(21).

PMID: 37958848 PMC: 10647335. DOI: 10.3390/ijms242115866.


Cell-Type-Specific Gene Regulatory Networks of Pro-Inflammatory and Pro-Resolving Lipid Mediator Biosynthesis in the Immune System.

Hoch M, Rauthe J, Cesnulevicius K, Schultz M, Lescheid D, Wolkenhauer O Int J Mol Sci. 2023; 24(5).

PMID: 36901771 PMC: 10001763. DOI: 10.3390/ijms24054342.


Non-Coding RNAs in Cell-to-Cell Communication: Exploiting Physiological Mechanisms as Therapeutic Targets in Cardiovascular Pathologies.

Laura Frances J, Musolino E, Papait R, Pagiatakis C Int J Mol Sci. 2023; 24(3).

PMID: 36768528 PMC: 9916956. DOI: 10.3390/ijms24032205.


References
1.
Lafyatis R, Lechleider R, Kim S, Jakowlew S, Roberts A, Sporn M . Structural and functional characterization of the transforming growth factor beta 3 promoter. A cAMP-responsive element regulates basal and induced transcription. J Biol Chem. 1990; 265(31):19128-36. View

2.
Kim S, Jeang K, Glick A, Sporn M, Roberts A . Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoinduction. J Biol Chem. 1989; 264(12):7041-5. View

3.
Majesky M, Lindner V, Twardzik D, Schwartz S, Reidy M . Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest. 1991; 88(3):904-10. PMC: 295478. DOI: 10.1172/JCI115393. View

4.
Poston R, Haskard D, Coucher J, Gall N . Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol. 1992; 140(3):665-73. PMC: 1886152. View

5.
Nikol S, Isner J, Pickering J, Kearney M, Leclerc G, Weir L . Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest. 1992; 90(4):1582-92. PMC: 443206. DOI: 10.1172/JCI116027. View